Data / Form D filings / Matrix-Bio, Inc.
Matrix-Bio, Inc.: Form D filing
Matrix-Bio, Inc., a biotechnology company in West Lafayette, IN, filed a Form D with the SEC in 2011. The latest, on February 2, 2011, reports $140,000 sold of a $250,000 offering to 5 investors.
Find out what Matrix-Bio, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1281 WIN HENTSCHEL, West Lafayette, IN, 47906
- Phone
- (765) 418-3200
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1511413
The full lists. Form D filings in Indiana: 436 rows, $21.80, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 2, 2011 | New notice | $250,000 | $140,000 | $110,000 | 5 | Jan 24, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel Raftery | Executive Officer, Director |
Other biotechnology companies in Indiana that filed recently
- PAHTIA TECHNOLOGIES INC $25,000 · Sep 17, 2026
Every Form D from the week of Jan 31, 2011 · All recent filings in Indiana · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Matrix-Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.